Citation: Je. Moulder et al., ANGIOTENSIN-II RECEPTOR ANTAGONISTS IN THE TREATMENT AND PREVENTION OF RADIATION NEPHROPATHY, International journal of radiation biology, 73(4), 1998, pp. 415-421
Citation: Je. Moulder et al., RADIATION NEPHROPATHY IS TREATABLE WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR AN ANGIOTENSIN-II TYPE-1 (AT(1)) RECEPTOR ANTAGONIST, Radiotherapy and oncology, 46(3), 1998, pp. 307-315
Citation: Wr. Hendee et al., PROPOSITION - RADIATION HORMESIS SHOULD BE ELEVATED TO A POSITION OF SCIENTIFIC RESPECTABILITY, Medical physics, 25(8), 1998, pp. 1407-1410
Citation: Sc. Miller et Je. Moulder, PUBLICATION OF NEGATIVE RESULTS IS AN ESSENTIAL PART OF THE SCIENTIFIC PROCESS, Radiation research, 150(1), 1998, pp. 1-2
Authors:
COHEN EP
PIERING WF
KABLERBABBITT C
MOULDER JE
Citation: Ep. Cohen et al., END-STAGE RENAL-DISEASE (ESRD) AFTER BONE-MARROW TRANSPLANTATION - POOR SURVIVAL COMPARED TO OTHER CAUSES OF ESRD, Nephron, 79(4), 1998, pp. 408-412
Authors:
COHEN EP
KABLERBABBITT C
PIERING WF
MOULDER JE
Citation: Ep. Cohen et al., END-STAGE RENAL-DISEASE AFTER MARROW TRANSPLANTATION - HIGHER MORTALITY COMPARED TO OTHER CAUSES OF ESRD, Journal of the American Society of Nephrology, 8, 1997, pp. 641-641
Citation: Ep. Cohen et al., ANGIOTENSIN-II - ENHANCEMENT OF RADIATION NEPHROPATHY (RAD NP), Journal of the American Society of Nephrology, 8, 1997, pp. 2852-2852
Authors:
TWINING SS
SCHULTE DP
ZHOU XY
WILSON PM
FISH BL
MOULDER JE
Citation: Ss. Twining et al., CHANGES IN RAT CORNEAL MATRIX METALLOPROTEINASES AND SERINE PROTEINASES UNDER VITAMIN-A-DEFICIENCY, Current eye research, 16(2), 1997, pp. 158-165
Authors:
LAWTON CA
COHEN EP
MURRAY KJ
DERUS SW
CASPER JT
DROBYSKI WR
HOROWITZ MM
MOULDER JE
Citation: Ca. Lawton et al., LONG-TERM RESULTS OF SELECTIVE RENAL SHIELDING IN PATIENTS UNDERGOINGTOTAL-BODY IRRADIATION IN PREPARATION FOR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(12), 1997, pp. 1069-1074
Citation: Je. Moulder et al., NONCONTINUOUS USE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF EXPERIMENTAL BONE-MARROW TRANSPLANT NEPHROPATHY, Bone marrow transplantation, 19(7), 1997, pp. 729-735
Citation: Ep. Cohen et al., SUCCESSFUL BRIEF CAPTOPRIL TREATMENT IN EXPERIMENTAL RADIATION NEPHROPATHY, The Journal of laboratory and clinical medicine, 129(5), 1997, pp. 536-547
Citation: Kr. Foster et al., WEAK ELECTROMAGNETIC-FIELDS AND CANCER IN THE CONTEXT OF RISK ASSESSMENT, Proceedings of the IEEE, 85(5), 1997, pp. 733-746
Authors:
TWINING SS
SCHULTE DP
WILSON PM
ZHOU XY
FISH BL
MOULDER JE
Citation: Ss. Twining et al., NEUTROPHIL CATHEPSIN-G IS SPECIFICALLY DECREASED UNDER VITAMIN-A-DEFICIENCY, Biochimica et biophysica acta. Molecular basis of disease, 1317(2), 1996, pp. 112-118
Authors:
WARD WF
MOULDER JE
FISH BL
MOLTENI A
GORDON LI
TAYLOR JM
Citation: Wf. Ward et al., ACUTE LUNG REACTIONS IN A RAT MODEL OF POST-BONE MARROW TRANSPLANTATION PNEUMONITIS, The FASEB journal, 10(3), 1996, pp. 627-627
Citation: Je. Moulder, BIOLOGICAL STUDIES OF POWER-FREQUENCY FIELDS AND CARCINOGENESIS, IEEE engineering in medicine and biology magazine, 15(4), 1996, pp. 31
Citation: Je. Moulder et al., ANGIOTENSIN-II RECEPTOR ANTAGONISTS IN THE PREVENTION OF RADIATION NEPHROPATHY, Radiation research, 146(1), 1996, pp. 106-110
Authors:
COHEN EP
MOLTENI A
HILL P
FISH BL
WARD WF
MOULDER JE
CARONE FA
Citation: Ep. Cohen et al., CAPTOPRIL PRESERVES FUNCTION AND ULTRASTRUCTURE IN EXPERIMENTAL RADIATION NEPHROPATHY, Laboratory investigation, 75(3), 1996, pp. 349-360
Authors:
COHEN EP
NORMAN JT
FINE LG
FISH BL
MOULDER JE
Citation: Ep. Cohen et al., PREVENTION OF INTERSTITIAL FIBROBLAST ACTIVATION IN RADIATION NEPHRITIS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1011-1011